U.S. flag

An official website of the United States government

NM_001122681.2(SH3BP2):c.17del (p.Met6fs) AND Fibrous dysplasia of jaw

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jan 19, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000814840.7

Allele description [Variation Report for NM_001122681.2(SH3BP2):c.17del (p.Met6fs)]

NM_001122681.2(SH3BP2):c.17del (p.Met6fs)

Gene:
SH3BP2:SH3 domain binding protein 2 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
4p16.3
Genomic location:
Preferred name:
NM_001122681.2(SH3BP2):c.17del (p.Met6fs)
HGVS:
  • NC_000004.12:g.2820634del
  • NG_011609.1:g.32612del
  • NM_001122681.2:c.17delMANE SELECT
  • NM_001145855.2:c.101del
  • NM_001145856.2:c.188del
  • NM_003023.4:c.17del
  • NP_001116153.1:p.Met6fs
  • NP_001139327.1:p.Met34fs
  • NP_001139328.1:p.Met63fs
  • NP_003014.3:p.Met6fs
  • LRG_1334t1:c.17del
  • LRG_1334t2:c.101del
  • LRG_1334:g.32612del
  • LRG_1334p1:p.Met6fs
  • LRG_1334p2:p.Met34fs
  • NC_000004.11:g.2822361del
  • NC_000004.11:g.2822361delT
  • NM_003023.4:c.17delT
Protein change:
M34fs
Links:
dbSNP: rs746804160
NCBI 1000 Genomes Browser:
rs746804160
Molecular consequence:
  • NM_001122681.2:c.17del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001145855.2:c.101del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001145856.2:c.188del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_003023.4:c.17del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Fibrous dysplasia of jaw (CRBM)
Synonyms:
Cherubism
Identifiers:
MONDO: MONDO:0007315; MedGen: C0008029; Orphanet: 184; OMIM: 118400

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000955268Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jan 19, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000955268.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change creates a premature translational stop signal (p.Met6Serfs*7) in the SH3BP2 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in SH3BP2 cause disease. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SH3BP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 658097). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024